Today, we announced positive longer-term clinical data from the low dose cohort of our ongoing REVEAL Phase 1/2 adolescent and adult trial as well as initial clinical data from our REVEAL Phase 1/2 pediatric trial evaluating TSHA-102 in #Rettsyndrome. Tune in to our webcast today at 8:00 a.m. ET to discuss the clinical data. Read the press release and register for the webcast: https://lnkd.in/egEVTtVG
Congratulations. Great news for patients!
Phenomenal news!!
That’s great news Sean!!
Congrats Taysha
Congratulations! Exciting!
Sr. Director, Head of Analytical Sciences
4moThat is super exciting news. Best of luck!